by Gary Finnegan: Peanut and nut intake appear to lower mortality rates from major diseases, according to a new study, but peanut butter has no shown any protective… read more.
by Bruce Sylvester: Weakening grip strength is associated with increasing overall mortality and with increasing risk of heart attack or stroke, researchers from a large international study reported… read more.
by Bruce Sylvester: Older adults who use cholesterol-lowering statins or fibrates have one third less risk of stroke than their untreated counterparts, researchers reported on May 19, 2015… read more.
by Bruce Sylvester: Researchers reported on May 20, at American Thoracic Society/ATS 2015 annual meeting in Denver that the presence of chronic obstructive pulmonary disease, COPD, is an… read more.
In patients with HIV, a diabetes drug may have benefits beyond lowering blood sugar. A new study from researchers at Washington University School of Medicine in St. Louis… read more.
While the consequences of osteoporosis are worse in men than women – including death – older males are far less likely to take preventive measures against the potentially… read more.
by Bruce Sylvester: Rheumatoid arthritis is associated with an increased risk of no-warning heart attack, researchers reported on May 4, 2015 at ICNC 12 (International Conference on Nuclear… read more.
Researchers suggest that officials re-examine blood storage practice. Infants and children who undergo heart surgery are better off receiving fresh whole blood transfusions from a single donor, compared… read more.
by Bruce Sylvester: Compared to women who deliver at full-term, women with a history of spontaneous preterm delivery appear to have a doubled risk of developing heart disease,… read more.
by Bruce Sylvester: Atrial fibrillation patients treated with digoxin have a 27 percent greater risk of dying than atrial fibrillation patients not treated with the drug, according to… read more.
by Bruce Sylvester: Among patients with heart failure and atrial fibrillation, catheter ablation has led to lower mortality, hospitalization or recurrent atrial fibrillation than treatment with the heart… read more.
by Bruce Sylvester: Patients treated for one year with evolocumab, an investigative drug used to lower LDL cholesterol, have achieved significant reductions in mortality, heart attack and stroke,… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
